Cargando…

A case of generalized psoriasis-like skin lesions caused by rituximab use in a 14-years patient with systemic lupus erythematosus

Detalles Bibliográficos
Autores principales:	Rodionovskaya, SR, Nikishina, IP, Tsymbal, IN, Lavrentieva, IN
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194612/ http://dx.doi.org/10.1186/1546-0096-9-S1-P249

Ejemplares similares

A case of autoimmune lymphoproliferative syndrome in a 3 years-old patient
por: Lavrentieva, IN, et al.
Publicado: (2011)

PReS-FINAL-2076: Single centre experience of biologics in clinical practice of systemic juvenile idiopatic arthritis
por: Kaleda, MI, et al.
Publicado: (2013)

An experience of sequental use of three biologics and recombinant growth hormone in a patient with juvenile idiopathic arthritis associated with unsuccessful outcome of hip damage
por: Nikishina, IP, et al.
Publicado: (2011)

PReS-FINAL-2061: Abatacept in therapy of juvenile idiopathic arthritis in real clinical practice
por: Arsenyeva, SV, et al.
Publicado: (2013)

Ten years of experience of biologics in juvenile idiopathic arthritis: focus for the reasons of withdrawals
por: Arsenyeva, Svetlana V, et al.
Publicado: (2014)

Description Kelley-Seegmiller syndrome (partial HPRT deficiency manifesting as a gout-urolithiasis syndrome) in a patient of 15 years old
por: Rodionovskaya, SR, et al.
Publicado: (2011)

Rituximab reduces the hospitalization in patients with systemic lupus erythematosus
por: Martínez-Pérez, R, et al.
Publicado: (2010)

Analysis of rituximab’s usage for the treatment of pediatric systemic lupus erythematosus
por: Alves, Alessandra, et al.
Publicado: (2014)

Rituximab reduces anti-cardiolipin levels in patients with systemic lupus erythematosus
por: Martínez-Pérez, R, et al.
Publicado: (2010)

Tocilizumab therapy in systemic juvenile idiopathic arthritis – lessons of real clinical practice
por: Kaleda, Maria I, et al.
Publicado: (2014)

Rituximab for treatment of severe lupus nephritis
por: Baskin, E, et al.
Publicado: (2008)

Safety and efficacy of rituximab in refractory pediatric Systemic Lupus Erythematosus nephritis: a single-center experience of northern Greece
por: Trachana, M, et al.
Publicado: (2011)

PReS-FINAL-2310: Successful rituximab treatment in a 14 year-old boy with lupus nephritis
por: Torrente-Segarra, V, et al.
Publicado: (2013)

Effective use of rituximab in combination with low dose cyclophosphamide in childhood onset systemic lupus erythematosus (SLE) with relapsing class IV nephritis
por: Miettunen, PM, et al.
Publicado: (2008)

PReS-FINAL-2062: The need for conducting different rehabilitation complexes for patients with juvenile idiopathic arthritis (JIA)
por: Shelepina, TA, et al.
Publicado: (2013)

PReS-FINAL-2014: Excellent results of the conventional treatment in a child with late-diagnosed juvenile dermatomyositis with severe calcinosis
por: Nikishina, IP, et al.
Publicado: (2013)

An open-label safety and efficacy study of an anti-CD20 antibody (rituximab, Rituxan) for anti-B-cell therapy in the treatment of systemic lupus erythematosus
por: Eisenberg, RA, et al.
Publicado: (2004)

New aspects of the etiopathogenesis of systemic lupus erythematosus
por: Gaipl, US, et al.
Publicado: (2003)

Musculoskeletal sonography in juvenile systemic lupus erythematosus
por: Demirkaya, E, et al.
Publicado: (2008)

FDG-PET in juvenile systemic lupus erythematosus
por: Alberdi, M, et al.
Publicado: (2011)

Major infections in children with systemic lupus erythematosus
por: Costa Reis, Ana Patricia, et al.
Publicado: (2012)

The diagnosis of juvenile systemic lupus erythematosus with SLICC
por: Kısaarslan, Ayşenur Paç, et al.
Publicado: (2014)

Childhood-onset bullous systemic lupus erythematosus
por: Lourenço, Daniela, et al.
Publicado: (2014)

Particularities of anaemia in framework of systemic lupus erythematosus
por: Samohvalov, Elena, et al.
Publicado: (2012)

Evaluation of disease activity in a population of Russian JIA patients
por: Kostareva, OM, et al.
Publicado: (2011)

Endothelial function and activation in women with systemic lupus erythematosus
por: Svenungsson, E, et al.
Publicado: (2005)

Splenectomy for refractory thrombocytopenia in juvenile systemic lupus erythematosus
por: Campos, LMA, et al.
Publicado: (2008)

Liver involvement in juvenile systemic lupus erythematosus (SLE)
por: Mariniello, Generosa, et al.
Publicado: (2011)

Penile anthropometry in adolescents and adults systemic lupus erythematosus
por: Vecchi, Ana P, et al.
Publicado: (2011)

Social phobia in childhood-onset systemic lupus erythematosus
por: Nascimento, Catia, et al.
Publicado: (2014)

Rituximab is effective in the treatment of nephritis in lupus patients, refractory to conventional immunosuppressive therapy
por: Martínez, R, et al.
Publicado: (2010)

The effect of juvenile systemic lupus erythematosus serum activated macrophages on a lupus nephritis model
por: Vernon, April S, et al.
Publicado: (2014)

Surgical treatment of skin lesions in lupus erythematosus
por: Lewandowicz, Edward, et al.
Publicado: (2014)

Mri functional and tissue characterisation in patients with systemic lupus erythematosus
por: Gruber, Angela, et al.
Publicado: (2011)

MRI functional and tissue characterisation in patients with systemic lupus erythematosus
por: Buss, Sebastian, et al.
Publicado: (2012)

Clinical characteristics of cutaneous vasculitis secondary to systemic lupus erythematosus
por: Zhizho, Ye, et al.
Publicado: (2008)

Autoimmune hepatitis or systemic lupus erythematosus? A diagnostic dilemma
por: Makay, B, et al.
Publicado: (2008)

Bone mineral density in patients with juvenile systemic lupus erythematosus
por: Guenka, Ana Paula Roenick, et al.
Publicado: (2011)

Systemic lupus erythematosus in Saudi children: Long-term outcome
por: Al-Mayouf, Sulaiman M
Publicado: (2011)

Mycophenolate mofetil use in refractory juvenile systemic lupus erythematosus
por: Marques, R, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_cgd8ot3ubmae446ih6aht1kngs